Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on the development of a portfolio of product candidates to treat central nervous system (CNS) diseases.
A technology-driven healthcare services company, Medley Health is committed to redefining the doctor-patient relationship in order to achieve high quality, cost-effective primary and preventative health care.
Kite, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everythingwe do, from early research to product development
Foamix is working to solve some of today’s most difficult therapeutic challenges. With every problem we take on, our approach is the same: question traditional assumptions and find a better solution.
ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer, primarily focused on orphan and rare diseases.